Retraction
Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis
Paper Information
Record ID:
25064
Author(s):
Journal:
Publication Date:
July 06, 2005
Retraction Date:
January 13, 2021
(4.9 years years ago)
Subjects:
Institutions:
- Department of Periodontics, Prevention and Geriatrics, University of Michigan School of Dentistry, 1011 North University Avenue, Ann Arbor, MI 48109-1078, United States
- Department of Cariology, Restorative Sciences, and Endodontics, University of Michigan School of Dentistry, Ann Arbor, MI 48109-1078, United States
- Department of Biologic and Materials Sciences, Division of Prosthodontics, University of Michigan School of Dentistry, Ann Arbor, MI 48109-1078, United States
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.cellsig.2020.109909Citations (168)
168
Total Citations8
Post-Retraction(4.8%)
160
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
3
After 2+ years
1207
Days since retraction (latest)
Construction of a prognostic model for autophagy in Wilm's tumor
Haoyu Shi, Min Zhang, You-Bo Zhang
Pediatric Surgery International
Published: May 2024
1207 days after retraction
CD34+DNAM-1brightCXCR4+ haemopoietic precursors circulate after chemotherapy, seed lung tissue and generate functional innate-like T cells and NK cells
Carola Perrone, Federica Bozzano, Maria Giovanna Dal Bello et al. (14 authors)
Frontiers in Immunology
Open Access
Published: Feb 2024
4 citations
4 citations
1121 days after retraction
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications
Cinzia Baldessari, Stefania Pipitone, Eleonora Molinaro et al. (15 authors)
Cancers
Open Access
Published: Feb 2023
26 citations
26 citations
776 days after retraction
CXCL12–CXCR4 Axis in Cancer Metastasis
Manzoor Ahmad Mir, Ab Qayoom Naik, Mohd Zahoor ul haq Shah et al. (4 authors)
Unknown Journal
Published: Jan 2023
3 citations
3 citations
718 days after retraction
Prognostic significance of SDF-1 chemokine and its receptors CXCR4 and CXCR7 involved in EMT of prostate cancer
Martyna Parol‐Kulczyk, Arkadiusz Gzil, Joanna Ligmanowska et al. (4 authors)
Cytokine
Open Access
Published: Dec 2021
13 citations
13 citations
336 days after retraction
Neovascularization of engineered tissues for clinical translation: Where we are, where we should be?
Muhammad Anwaar Nazeer, İsmail Can Karaoğlu, Onur Ozer et al. (5 authors)
APL Bioengineering
Open Access
Published: Apr 2021
15 citations
15 citations
82 days after retraction
Retraction: A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer
Jianhua Wang, Jincheng Wang, Jinlu Dai et al. (13 authors)
Cancer Research
Open Access
Published: Mar 2021
2 citations
2 citations
61 days after retraction
Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune‐mediated diseases
C A Britton, Mark C. Poznansky, Patrick M. Reeves
The FASEB Journal
Published: Mar 2021
60 citations
60 citations
60 days after retraction
The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases
Shahid Hussain, Bo Peng, Mathew Cherian et al. (6 authors)
Frontiers in Immunology
Open Access
Published: Dec 2020
40 citations
40 citations
22 days before retraction
Molecular mechanisms and clinical management of cancer bone metastasis
Manni Wang, Fan Xia, Yuquan Wei et al. (4 authors)
Bone Research
Open Access
Published: Jul 2020
125 citations
125 citations
168 days before retraction
Anti-angiogenic effects of testis-specific gene antigen 10 on primary endothelial cells
Elahe Valipour, Vajihe Taghdiri Nooshabadi, Shadi Mahdipour et al. (10 authors)
Gene
Published: Jun 2020
5 citations
5 citations
222 days before retraction
Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy
Qi Fu, Zhenhai Yu
Life Sciences
Published: May 2020
71 citations
71 citations
228 days before retraction
CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer
Benedikt Jäger, Denise Klatt, Linda Plappert et al. (8 authors)
Cellular Signalling
Published: May 2020
43 citations
43 citations
242 days before retraction
T140 Inhibits Apoptosis and Promotes Proliferation and Matrix Formation Through the SDF-1/CXC Receptor-4 Signaling Pathway in Endplate Chondrocytes of the Rat Intervertebral Discs
Zhiyong Gao, Liang Yu, Ben-Xia Shi et al. (6 authors)
World Neurosurgery
Published: Aug 2019
5 citations
5 citations
502 days before retraction
The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases
Alexus D. Kolb, Karen M. Bussard
Cancers
Open Access
Published: Jul 2019
69 citations
69 citations
543 days before retraction
Evaluation of high molecular weight cytokeratin (HMWCK), p27, C-X-C chemokine receptor type 4 (CXCR-4) and stromal cell-derived factor 1 (SDF-1) expressions related to tumor progression in breast cancer
Gonca Özgün, Gülen Akyol
The European Research Journal
Open Access
Published: Jul 2019
546 days before retraction
Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway
Yin-Gi Jang, Ryu-Eun Go, Kyung‐A Hwang et al. (4 authors)
The Journal of Steroid Biochemistry and Molecular Biology
Published: Jun 2019
64 citations
64 citations
585 days before retraction
Growth factors involve in cellular proliferation, differentiation and migration during prostate cancer metastasis.
Ilaha Isali, Mohammed Al‐Sadawi, Arshna Qureshi et al. (6 authors)
PubMed
Published: Jan 2019
10 citations
10 citations
743 days before retraction
WHIM syndrome: Immunopathogenesis, treatment and cure strategies
David H. McDermott, Philip M. Murphy
Immunological Reviews
Published: Dec 2018
52 citations
52 citations
757 days before retraction
The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy
Yu Zhou, Hanbo Cao, Wenjun Li et al. (4 authors)
Chinese Journal of Natural Medicines
Published: Nov 2018
75 citations
75 citations
804 days before retraction
Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis
Nicola Graham, Bin‐Zhi Qian
International Journal of Molecular Sciences
Open Access
Published: Apr 2018
41 citations
41 citations
1010 days before retraction
Chemokines in homeostasis and diseases
Keqiang Chen, Zhiyao Bao, Peng Tang et al. (6 authors)
Cellular and Molecular Immunology
Open Access
Published: Jan 2018
178 citations
178 citations
1080 days before retraction
Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology
Lun K. Tsou, Ying‐Huey Huang, Jen‐Shin Song et al. (6 authors)
Medicinal Research Reviews
Published: Aug 2017
36 citations
36 citations
1260 days before retraction
The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism
Qingling Yang, Lingyu Zhang, Haifeng Wang et al. (13 authors)
Oncotarget
Open Access
Published: Mar 2017
9 citations
9 citations
1394 days before retraction
Inhibiting G protein βγ signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel
Prakash Paudyal, Qing Xie, Prasanna Kuma Vaddi et al. (5 authors)
Oncotarget
Open Access
Published: Mar 2017
12 citations
12 citations
1394 days before retraction
Local and transient gene expression primes the liver to resist cancer metastasis
Tyler J. Goodwin, Yingqiu Zhou, Sara Musetti et al. (5 authors)
Science Translational Medicine
Open Access
Published: Nov 2016
75 citations
75 citations
1526 days before retraction
Paper citing Diverse signaling pathways through the SDF-1/CXCR4...
Unknown Authors
Unknown Journal
Published: Nov 2016
1526 days before retraction
Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?
Sandra Casimiro, Arlindo R. Ferreira, André Mansinho et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Aug 2016
39 citations
39 citations
1600 days before retraction
CXCR4 and CCR7: Two eligible targets in targeted cancer therapy
Mohammad Amir Mishan, Naghmeh Ahmadiankia, Ahmad Reza Bahrami
Cell Biology International
Published: Jun 2016
56 citations
56 citations
1687 days before retraction
Significance of oral cancer‐associated fibroblasts in angiogenesis, lymphangiogenesis, and tumor invasion in oral squamous cell carcinoma
Nan-nan Lin, Ping Wang, Dan Zhao et al. (6 authors)
Journal of Oral Pathology and Medicine
Published: May 2016
54 citations
54 citations
1692 days before retraction
Symmetrical bis-tertiary amines as novel CXCR4 inhibitors
Renren Bai, Zhongxing Liang, Younghyoun Yoon et al. (9 authors)
European Journal of Medicinal Chemistry
Open Access
Published: Apr 2016
22 citations
22 citations
1727 days before retraction
Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals
Yingwu Zhao, Weizhi You, Jing Zheng et al. (6 authors)
Clinical & Translational Oncology
Published: Mar 2016
28 citations
28 citations
1776 days before retraction
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression
Christopher J. Coke, Kisha A. Scarlett, Mahandranauth A. Chetram et al. (8 authors)
Journal of Biological Chemistry
Open Access
Published: Feb 2016
89 citations
89 citations
1805 days before retraction
Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications
Aixiu Qiao, Feng Gu, Xiaojing Guo et al. (5 authors)
Frontiers of Medicine
Published: Jan 2016
69 citations
69 citations
1820 days before retraction
Involvement of CXCL12 Pathway in HPV-related Diseases
Nádia Calvo Martins Okuyama, Fernando Cezar dos Santos, Kleber Paiva Trugilo et al. (4 authors)
AIMS Medical Science
Open Access
Published: Jan 2016
2 citations
2 citations
1839 days before retraction
Molecular Mechanisms of Bone Metastasis.
Ulrich H. Weidle, Fabian Birzele, Gwendlyn Kollmorgen et al. (4 authors)
PubMed
Published: Dec 2015
77 citations
77 citations
1842 days before retraction
Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis
Xiaojin Li, Hua Guo, Hongyang Duan et al. (8 authors)
Scientific Reports
Open Access
Published: Nov 2015
40 citations
40 citations
1896 days before retraction
DFO Enhances the Targeting of CD34-Positive Cells and Improves Neovascularization
Zijing Du, Tao Zan, Xiaolu Huang et al. (7 authors)
Cell Transplantation
Open Access
Published: Oct 2015
6 citations
6 citations
1903 days before retraction
Dermal fibroblast expression of stromal cell-derived factor-1 (SDF-1) promotes epidermal keratinocyte proliferation in normal and diseased skin
Chunji Quan, Moon Kyun Cho, Yuan Shao et al. (7 authors)
Protein & Cell
Open Access
Published: Aug 2015
70 citations
70 citations
1972 days before retraction
Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers
Venkat R. Katkoori, Marc D. Basson, Vincent C. Bond et al. (5 authors)
Oncotarget
Open Access
Published: Jul 2015
28 citations
28 citations
1997 days before retraction
miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis
Xiaojuan Sun, Cherie Charbonneau, Wei Lei et al. (5 authors)
Molecular Cancer Research
Open Access
Published: May 2015
67 citations
67 citations
2058 days before retraction
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
Fangyu Guo, Y Wang, Jinyun Liu et al. (6 authors)
Oncogene
Open Access
Published: May 2015
423 citations
423 citations
2074 days before retraction
The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing
Annick Mühlethaler‐Mottet, Julie Liberman, Kelly Ascenção et al. (9 authors)
PLoS ONE
Open Access
Published: May 2015
29 citations
29 citations
2077 days before retraction
SGK3 (CISK) may induce tumor angiogenesis (Hypothesis)
Minzhi Hou, Yingrong Lai, Shanyang He et al. (6 authors)
Oncology Letters
Open Access
Published: May 2015
13 citations
13 citations
2079 days before retraction
Attenuation of cartilage pathogenesis in post-traumatic osteoarthritis (PTOA) in mice by blocking the stromal derived factor 1 receptor (CXCR4) with the specific inhibitor, AMD3100
Nathan P. Thomas, Pengcui Li, Braden C. Fleming et al. (8 authors)
Journal of Orthopaedic Research®
Open Access
Published: Mar 2015
28 citations
28 citations
2144 days before retraction
Cancer-associated fibroblasts: A multifaceted driver of breast cancer progression
Haojun Luo, Gang Tu, Zhimin Liu et al. (4 authors)
Cancer Letters
Published: Feb 2015
190 citations
190 citations
2156 days before retraction
Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion
Fuxiang Yu, Weijian Hu, Bin He et al. (6 authors)
World Journal of Surgical Oncology
Open Access
Published: Feb 2015
34 citations
34 citations
2159 days before retraction
Chronic inflammatory mediators enhance prostate cancer development and progression
Dinesh Thapa, Rita Ghosh
Biochemical Pharmacology
Published: Jan 2015
55 citations
55 citations
2193 days before retraction
A systematic approach to prioritize drug targets using machine learning, a molecular descriptor-based classification model, and high-throughput screening of plant derived molecules: a case study in oral cancer
Vinay Randhawa, Anil Kumar Singh, Vishal Acharya
Molecular BioSystems
Published: Jan 2015
10 citations
10 citations
2204 days before retraction
Cell-Cell Fusion, Chemotaxis and Metastasis
George E. Parris
Springer eBooks
Published: Jan 2015
2204 days before retraction
Quick Stats
Total Citations:
168
Years Since Retraction:
4.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025